CareFusion Reports In-Line Quarter/Guidance

Shares of CareFusion CFN are trading lower in the after-hours following the release of the company's Q1 earnings results. Currently, shares are lower by 0.83%, trading at $25.10; they ended the regular session higher by 0.20%, at $25.31. CareFusion reported Q1 EPS of $0.33 on revenues of $844 million; the Street was looking for $0.33 per share on $842.22 million in revenues. Revenues increased 4.1% year over year. The company sees FY2012 EPS in the range of $1.80-1.90; the Street was at $1.84 per share. "Our revenue and adjusted earnings per share growth for the quarter was driven by increased sales in our Dispensing Technologies and Infusion Systems businesses and the benefit from a lower tax rate," said Kieran Gallahue, chairman and CEO. "During the quarter, we transitioned from our stand-up phase to our foundation building stage, and made progress in our efforts to simplify how we do business and invest in areas to help expand margins and accelerate our top line growth.” CareFusion Corporation is a global medical technology company. The company offers product lines in the areas of IV infusion, medication and supply dispensing, respiratory care, infection prevention and surgical instruments. countries.